COMMUNICATIONS
Akio Baba et al.
erythro-2-(Hydroxy-4'-methoxyphenylmethyl)-1-phenyl-
(CDCl , 270 MHz): d 0.78 (t, J 7.32 Hz, 3H), 1.63 ± 2.00 (m,
3
±1 1
butan-1-one (syn-5a): IR(neat): n 3494, 1666 cm ; H NMR
2H), 3.36 (d, J 1.95 Hz, 1H), 3.64 ± 3.72 (m, 1H), 5.07 (dd, J
(
2
4
(
5
2
1
CDCl , 270 MHz): d 0.79 (t, J 7.81 Hz, 3H), 1.70 ± 2.03 (m,
4.40 and 1.95 Hz, 1H), 7.23 ± 7.37 (m, 4H), 7.40 ± 7.63 (m, 3H),
3
1
3
H), 3.05 (br, 1H), 3.77 (s, 3H), 3.66 ± 3.83 (m, 1H), 5.03 (dd, J
7.86 ± 7.93 (m, 2H); C NMR(CDCl , 67.9 MHz): d 12.2,
3
.40 Hz, 1H), 6.77 ± 6.86 (m, 2H), 7.24 ± 7.60 (m, 5H), 7.84 ± 7.90
20.4, 53.8, 73.0, 127.6, 128.3, 128.4, 128.8, 133.1, 133.6, 137.2,
140.5, 205.2; MS: m/z 288 (15), 270 (9), 259 (52), 148 (100),
139 (51), 133 (66), 111 (23), 105 (89), 91 (5), 77 (55); HRMS:
calcd. for C H ClO : 288.0917; found: 288.0916.
m, 2H); 13C NMR (CDCl , 67.9 MHz): d 12.1, 20.7, 54.2,
3
5.2, 73.5, 113.6, 127.3, 128.3, 128.6, 133.3, 134.2, 137.5, 158.9,
05.2; MS: m/z 284 (10), 255 (11), 148 (94), 135 (100), 120 (9),
05 (99), 92 (9), 77 (54); HRMS: calcd. for C H O : 284.1413;
1
7
17
2
threo-2-(Hydroxy-4'-nitrophenylmethyl)-1-phenylbutan-1-
1
8
20
3
±
1 1
found: 284.1414.
one (anti-5f): IR(neat): n 3433, 1674 cm ; H NMR (CDCl ,
3
threo-2-(Hydroxy-4'-methylphenylmethyl)-1-phenylbutan-
270 MHz): d 0.92 (t, J 7.32 Hz, 3H), 1.64 ± 1.89 (m, 2H),
3.69 ± 3.85 (m, 1H), 3.82 (d, J 6.84 Hz, 1H), 5.14 (dd, J 6.35
and 6.84 Hz, 1H), 7.38 ± 7.65 (m, 5H), 7.80 ± 7.88 (m, 2H), 8.12 ±
±1
1
1
(
(
1
7
6
1
(
(
-one (anti-5b): IR(neat): n 3463, 1674 cm ; H NMR
CDCl , 270 MHz): d 0.79 (t, J 7.33 Hz, 3H), 1.41 ± 1.80
3
1
3
m, 2H), 2.32 (s, 3H), 2.93 (d, J 4.88 Hz, 1H), 3.69 ± 3.83 (m,
8.20 (m, 2H); C NMR (CDCl
3
, 67.9 MHz): d 11.8, 23.8, 53.5,
H), 4.98 (dd, J 4.88 and 7.33 Hz, 1H), 7.08 ± 7.33 (m, 4H),
74.3, 123.6, 127.0, 128.2, 128.8, 133.8, 137.3, 147.3, 150.3, 205.2;
1
3
.40 ± 7.60 (m, 3H), 7.90 ± 7.98 (m, 2H); C NMR (CDCl ,
MS: m/z 299 (5), 270 (13), 177 (13), 148 (100), 133 (42), 120
3
7.9 MHz): d 11.6, 21.1, 23.7, 54.3, 75.6, 126.4, 128.3, 128.6,
(6), 105 (85), 91 (3), 77 (34); HRMS: calcd. for C17
H17ClO :
2
29.1, 133.1, 137.5, 138.3, 139.7, 205.6; MS: m/z 268 (18), 250
299.1157; found: 299.1158.
5), 239 (25), 148 (100), 133 (47), 119 (35), 105 (70), 91 (33), 77
34); HRMS: calcd. for C H O : 268.1463; found: 268.1457.
erythro-2-(Hydroxy-4'-nitrophenylmethyl)-1-phenylbutan-
±1
1
1-one (syn-5f): IR(neat): n 3437, 1674 cm ; H NMR
1
8
20
2
(
CDCl , 270 MHz): d 0.77 (t, J 7.32 Hz, 3H), 1.61 ± 2.00
erythro-2-(Hydroxy-4'-methylphenylmethyl)-1-phenylbu-
3
-1
1
(m, 2H), 3.69 (d, J 1.46 Hz, 1H), 3.69 ± 3.84 (m, 1H), 5.21 (dd,
J 3.42 and 1.46 Hz, 1H), 7.38 ± 7.69 (m, 5H), 7.78 ± 7.99 (m,
tan-1-one (syn-5b): IR(neat): n 3463, 1674 cm ; H NMR
(
CDCl , 270 MHz): d 0.78 (t, J 7.32 Hz, 3H), 1.63 ± 2.03 (m,
3
1
3
2
1
H), 8.10 ± 8.26 (m, 2H); C NMR (CDCl , 67.9 MHz): d
2
5
7
6
1
H), 2.30 (s, 3H), 3.14 (d, J 1.46 Hz, 1H), 3.68 ± 3.81 (m, 1H),
.06 (dd, J 1.46 and 3.90 Hz, 1H), 7.08 ± 7.32 (m, 4H), 7.40 ±
3
2.2, 20.3, 53.3, 72.8, 123.5, 127.1, 128.4, 128.9, 133.9, 136.8,
1
3
147.2, 149.5, 204.9; MS: m/z 299 (6), 270 (23), 177 (6), 148
100), 133 (50), 120 (7), 105 (89), 91 (4), 77 (40); HRMS: calcd.
for C H ClO : 299.1158; found: 299.1155.
.60 (m, 3H), 7.86 ± 7.94 (m, 2H); C NMR (CDCl ,
3
(
7.9 MHz): d 12.1, 20.4, 21.1, 54.1, 73.6, 126.1, 128.3, 128.6,
28.9, 133.3, 137.0, 137.4, 139.0, 205.3; MS. m/z 268 (18), 250
17 17
2
CAS Registry Nos.: 1,3-diphenylpropan-1-one (2a), [1083-
0-3]; 1-phenylbutan-1-one (2b), [495-40-9]; 4,4-dimethyl-1-
(
(
7), 239 (38), 148 (100), 133 (52), 119 (48), 105 (81), 91 (41), 77
41); HRMS: calcd. for C H O : 268.1463; found: 268.1464.
3
1
8
20
2
phenylpentan-1-one (2c), [37608-93-8]; 4-phenylbutan-2-one
(2d), [2550-26-7]; 4,4-dimethyl-1-phenylpentan-3-one (2e),
threo-2-(Hydroxy-4'-phenylphenylmethyl)-1-phenylbutan-
±1
1
1
(
(
-one (anti-5c): IR(neat): n 3475, 1677 cm ; H NMR
[
[
5195-24-4]; 2-benzyl-1,3,5-triphenylpentane-1,5-dione (3a),
38335-02-3]; 2-(hydroxyphenylmethyl)-1-phenylbutan-1-one
CDCl , 270 MHz): d 0.84 (t, J 7.32 Hz, 3H), 1.50 ± 1.86
3
m, 2H), 3.12 (d, J 5.37 Hz, 1H), 3.76 ± 3.87 (m, 1H), 5.08 (dd,
(
5d), [60669-63-8].
J 7.32 and 5.37 Hz, 1H), 7.23 ± 7.61 (m, 12H), 7.91 ± 7.98 (m,
2
1
1
H); 13C NMR (CDCl , 67.9 MHz): d 11.6, 23.7, 54.2, 75.4,
3
26.8, 127.0, 127.2, 127.3, 128.3, 128.6, 128.8, 131.2, 138.2, 140.6,
40.7, 141.8, 205.6; MS: m/z 330 (4), 301 (7), 182 (100), 148 Acknowledgements
(
69), 133 (27), 120 (7), 105 (75), 90 (5), 77 (36); HRMS: calcd.
for C H O : 330.1620; found: 330.1613.
23
22
2
This work was financially supported by a Grant-in-Aid for
Scientific Research from the Ministry of Education, Science and
Culture, and JSPS Research Fellowships for Young Scientists.
erythro-2-(Hydroxy-4'-phenylphenylmethyl)-1-phenylbu-
±
1
1
tan-1-one (syn-5c): IR(neat): n 3460, 1674 cm ; H NMR
(
2
CDCl , 270 MHz): d 0.81 (t, J 7.32 Hz, 3H), 1.70 ± 2.08 (m,
3
H), 3.26 (d, J 1.95 Hz, 1H), 3.74 ± 3.83 (m, 1H), 5.14 (dd, J
1
.95 and 4.39 Hz, 1H), 7.23 ± 7.61 (m, 12H), 7.88 ± 7.95 (m, 2H);
References and Notes
13
C NMR(CDCl , 67.9 MHz): d 12.1, 20.5, 54.0, 73.5, 126.6,
3
1
1
26.8, 127.0, 127.2, 128.3, 128.6, 128.7, 133.4, 137.4, 140.3, 140.8,
[
1] Barbier-type allylation: a) S. Araki, H. Ito, Y. Butsugan, J.
Org. Chem. 1988, 53, 1831 ± 1833; b) C. J. Li, T. H. Chan,
Tetrahedron Lett. 1991, 32, 7017 ± 7020; c) C. J. Li, T. H.
Chan, Tetrahedron 1999, 55, 11149 ± 11176; d) C. J. Li,
Tetrahedron Lett. 1995, 36, 517 ± 518; e) M. B. Isaac, T. H.
Chan, Tetrahedron Lett. 1995, 36, 8957 ± 8960; f) L. A.
Paquette, T. M. Mitzel, J. Org. Chem. 1996, 61, 8799-8804;
Pd-catalyzed allylation: g) S. Araki, T. Kamei, T. Hira-
shita, H. Yamamura, M. Kawai, Org. Lett. 2000, 2, 847-
849; pinacol coupling: h) H. J. Lim, G. Keum, S. B. Kang,
B. Y. Chung, Y. Kim, Tetrahedron Lett. 1998, 39, 4367-
4368; transmetallation: i) J. A. Marshall, K. W. Hinkle, J.
Org. Chem. 1995, 60, 1920 ± 1921; j) J. A. Marshall, K. W.
Hinkle, J. Org. Chem. 1996, 61, 105 ± 108; k) M. Yasuda, T.
Miyai, I. Shibata, R. Nomura, H. Matsuda, A. Baba,
41.1, 205.3; MS: m/z 330 (3), 301 (5), 182 (100), 148 (51), 133
(
23), 120 (6), 105 (63), 90 (5), 77 (32); HRMS: calcd. for C H
23 22
O : 330.1620; found: 330.1634.
2
threo-2-(Hydroxy-4'-chlorophenylmethyl)-1-phenylbutan-
±1
1
1
(
(
-one (anti-5e): IR(neat): n 3433, 1674 cm ; H NMR
CDCl , 270 MHz): d 0.83 (t, J 7.32 Hz, 3H), 1.48 ± 1.79
3
m, 2H), 3.29 (d, J 5.86 Hz, 1H), 3.64 ± 3.79 (m, 1H), 5.00 (dd,
J 6.35 and 5.86 Hz, 1H), 7.23 ± 7.36 (m, 4H), 7.40 ± 7.63 (m,
1
3
3
1
1
1
H), 7.84 ± 7.94 (m, 2H); C NMR (CDCl , 67.9 MHz): d
3
1.7, 23.7, 54.1, 74.8, 127.7, 128.2, 128.5, 128.6, 133.4, 137.9,
41.3, 205.5; MS: m/z 288 (15), 270 (7), 259 (34), 148 (100),
39 (42), 133 (62), 111 (20), 105 (83), 91 (5), 77 (52); HRMS:
calcd. for C H ClO : 288.0917; found: 288.0918.
17
17
2
erythro-2-(Hydroxy-4'-chlorophenylmethyl)-1-phenylbu-
tan-1-one (syn-5e): IR(neat): n 3433, 1674 cm ; H NMR
±1
1
286
Adv. Synth. Catal. 2002, 344, 283 ± 287